Goes without saying that drug/vax companies should not be designing, running and reporting trials on their own drugs as a basis for regulatory approval.
— David Bell (@bell00david) August 31, 2022
Any rational human would surely see that.
Yet recently the company that paid history’s highest fraud payout was allowed to. https://t.co/KcfOtgTU95
The host is Maajid Nawaz. The guest is Cardiologist, Dr. Aseem Malhotra.
Very, very bad in the corruption. They will design the trials that are likely to given them the outcome that they want. They then hold onto the raw data, and often what's interesting is what people don't know is that the very data that drives the conclusion of the trial that then are approved by the regulator, we'll come to the regulatory in a minute. they keep that confidential. And historically, when independent researchers have been able to access that raw data through litigation or through campaigns and looked at that data that drove the results of the trial that suggested the drug was positive, it would reverse the conclusion. So, something that was thought to be safe today, tomorrow is then found to be the opposite: not safe, and not very effective. So that's just giving you a snapshot of how important getting the raw data is. So, they control the data. We have to trust their summary results. The regulator, the BMJ did an investigation on this a couple of weeks ago to expose . . . by Maryanne Demasi, who is prolific in medical investigations, "From FDA to MHRA: Are Drug Regulators for Hire?" she's done that for many years.
Patients and doctors expect drug regulators to provide an unbiased, rigorous assessment of investigational medicines before they hit the market. But do they have sufficient independence from the companies they are meant to regulate?
And what they found was that most of the major regulators of the western countries are funded by the drug industry. So, the FDA takes about 65% of their money from the drug industry. The MHRA [a British regulatory agency] in this country, 86%. So, this is a big conflict of interest.
Over the past decades, regulatory industries have seen large proportions of their budgets funded by the industries they are sworn to regulate.
That's the medicines and health medicines of the MRHA . . .
In Europe, industry fees funded 20% of the new EU-wide regulator, the European Medicines Agency, (EMA), in 1995. By 2010, that had risen to 75%; today, it's 89%.
We need to dissociate; they need to be publicly funded bodies. The drug industry can produce drugs, but they then shouldn't be able to test them, then hide the data, and then we just rely on the information that they give us for their profit-making incentives.
A prime example of what he's talking about.
FDA will likely authorize the Omicron vaccine later today/tomorrow based on data from 8 mice and no human clinical data avail to the public. Americans deserve to see the data. Why is the White House/Dr. Jha pushing it so hard & universally w/o public data? https://t.co/mfgyJnHOiv
— Marty Makary MD, MPH (@MartyMakary) August 31, 2022
No comments:
Post a Comment